Date published: 2025-10-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

EF-CAB5 Activators

Forskolin, a known adenylyl cyclase stimulator, raises cyclic AMP levels, triggering protein kinase A into action, which in turn phosphorylates target proteins, potentially including EF-CAB5. IBMX, another agent that boosts cAMP and cGMP concentrations, works by inhibiting the enzymes that degrade these cyclic nucleotides, leading to amplified signaling through kinases like PKA and PKG, pathways that can intersect with EF-CAB5's activation. Calcium ion flux is a pivotal player in the activation of EF-CAB5. Ionomycin, a calcium ionophore, directly increases intracellular calcium, which then stimulates calmodulin-dependent kinases capable of modifying proteins through phosphorylation, a possible route to EF-CAB5's activation. PMA, a diacylglycerol analog, activates protein kinase C, inducing phosphorylation events with potential repercussions for EF-CAB5. The phospholipase C pathway, perturbed by U73122, results in altered diacylglycerol and inositol triphosphate levels, with a cascade effect that may impinge upon EF-CAB5's state.

Inhibitors like LY294002 and PD98059 reshape the intracellular signaling landscape by targeting PI3K and MEK, respectively. These disruptions in signaling can lead to a reconfiguration of EF-CAB5 activation due to changes in downstream targets. AICAR, by activating AMPK, influences various metabolic and stress-related signals that are likely to impact EF-CAB5's activity. The modulation of the p38 MAPK pathway by SB203580 and the JNK pathway by SP600125 lead to alterations in transcription factor activities and cellular responses, which are probable avenues for EF-CAB5 activation. Furthermore, okadaic acid's inhibition of protein phosphatases such as PP1 and PP2A ensures that phosphorylated proteins remain so, thereby skewing the cellular environment towards a state that supports EF-CAB5 activation. Thapsigargin, by impeding the function of the SERCA pump, causes a rise in cytosolic calcium levels, again favoring conditions that activate calcium-responsive kinases and possibly EF-CAB5.

SEE ALSO...

Items 11 to 11 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$94.00
$349.00
114
(2)

Inhibits the SERCA pump, raising cytosolic calcium levels, which can then activate kinases that phosphorylate EF-CAB5.